These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22578975)

  • 1. Difficult and complex separation from cardiopulmonary bypass in high-risk cardiac surgical patients: a multicenter study.
    Denault AY; Tardif JC; Mazer CD; Lambert J;
    J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):608-16. PubMed ID: 22578975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery.
    Salis S; Mazzanti VV; Merli G; Salvi L; Tedesco CC; Veglia F; Sisillo E
    J Cardiothorac Vasc Anesth; 2008 Dec; 22(6):814-22. PubMed ID: 18948034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between renal dysfunction requiring renal replacement therapy and promoter polymorphism of the erythropoietin gene in cardiac surgery.
    Popov AF; Schulz EG; Schmitto JD; Coskun KO; Tzvetkov MV; Kazmaier S; Zimmermann J; Schöndube FA; Quintel M; Hinz J
    Artif Organs; 2010 Nov; 34(11):961-8. PubMed ID: 21092038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative hemodynamic instability during and after separation from cardiopulmonary bypass.
    Denault AY; Deschamps A; Couture P
    Semin Cardiothorac Vasc Anesth; 2010 Sep; 14(3):165-82. PubMed ID: 20656747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery.
    Doenst T; Wijeysundera D; Karkouti K; Zechner C; Maganti M; Rao V; Borger MA
    J Thorac Cardiovasc Surg; 2005 Oct; 130(4):1144. PubMed ID: 16214532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inflammatory response to cardiac surgery with cardiopulmonary bypass: should steroid prophylaxis be routine?
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2012 Oct; 26(5):952-8. PubMed ID: 22765991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heart surgery with cardiopulmonary bypass in patients on chronic dialysis treatment: our experience].
    Galli R; Nicolini F; Pace Napoleone C; Longo M; Fiorani V; Cattabriga I; Busi T; Santoro A; Piovaccari GC; Grillone G; Branzi A; Pierangeli A
    G Ital Cardiol; 1996 Sep; 26(9):1025-30. PubMed ID: 9036040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass.
    Lazar HL; Bokesch PM; van Lenta F; Fitzgerald C; Emmett C; Marsh HC; Ryan U;
    Circulation; 2004 Sep; 110(11 Suppl 1):II274-9. PubMed ID: 15364875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass.
    Bennett-Guerrero E; Swaminathan M; Grigore AM; Roach GW; Aberle LG; Johnston JM; Fink MP
    J Cardiothorac Vasc Anesth; 2009 Jun; 23(3):324-9. PubMed ID: 18835526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between fibrinogen levels after cardiopulmonary bypass and large volume red cell transfusion in cardiac surgery: an observational study.
    Karkouti K; Callum J; Crowther MA; McCluskey SA; Pendergrast J; Tait G; Yau TM; Beattie WS
    Anesth Analg; 2013 Jul; 117(1):14-22. PubMed ID: 23687229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incremental value of thrombelastography for prediction of excessive blood loss after cardiac surgery: an observational study.
    Wasowicz M; McCluskey SA; Wijeysundera DN; Yau TM; Meinri M; Beattie WS; Karkouti K
    Anesth Analg; 2010 Aug; 111(2):331-8. PubMed ID: 20610554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does preoperative B-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard European System for Cardiac Operative Risk Evaluation after cardiac surgery?
    Fellahi JL; Daccache G; Rubes D; Massetti M; Gérard JL; Hanouz JL
    J Cardiothorac Vasc Anesth; 2011 Apr; 25(2):256-62. PubMed ID: 20674395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Logistic risk model predicting postoperative renal failure requiring dialysis in cardiac surgery patients.
    Rahmanian PB; Kwiecien G; Langebartels G; Madershahian N; Wittwer T; Wahlers T
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):701-7. PubMed ID: 21334918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemofiltration during cardiopulmonary bypass does not decrease the incidence of atrial fibrillation after cardiac surgery.
    Mauermann WJ; Nuttall GA; Cook DJ; Hanson AC; Schroeder DR; Oliver WC
    Anesth Analg; 2010 Feb; 110(2):329-34. PubMed ID: 19933534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amrinone in cardiac surgical patients with left-ventricular dysfunction. A prospective, randomized placebo-controlled trial.
    Butterworth JF; Royster RL; Prielipp RC; Lawless ST; Wallenhaupt SL
    Chest; 1993 Dec; 104(6):1660-7. PubMed ID: 8252937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of low cardiac output syndrome after isolated mitral valve surgery.
    Maganti M; Badiwala M; Sheikh A; Scully H; Feindel C; David TE; Rao V
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):790-6. PubMed ID: 20152992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
    Bokesch PM; Szabo G; Wojdyga R; Grocott HP; Smith PK; Mazer CD; Vetticaden S; Wheeler A; Levy JH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1022-9. PubMed ID: 21724197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoflurane, 0.5 minimum alveolar concentration administered through the precardiopulmonary bypass period, reduces postoperative dobutamine requirements of cardiac surgery patients: a randomized study.
    Ndoko SK; Tual L; Ait Mamar B; Sauvat S; Jabre P; Zakhouri M; Rosanval O; Abdi M; Kirsch M; Pouzet B; Loisance D; Dhonneur G
    J Cardiothorac Vasc Anesth; 2007 Oct; 21(5):683-9. PubMed ID: 17905274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury.
    Haase M; Bellomo R; Story D; Letis A; Klemz K; Matalanis G; Seevanayagam S; Dragun D; Seeliger E; Mertens PR; Haase-Fielitz A
    Nephrol Dial Transplant; 2012 Jan; 27(1):153-60. PubMed ID: 21677302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.